EKF Diagnostics (LON:EKF) Stock Price Up 12.3% – Time to Buy?

EKF Diagnostics Holdings plc (LON:EKF) traded up 12.3% during trading on Tuesday . The company traded as high as GBX 23.77 ($0.31) and last traded at GBX 23.02 ($0.30). 3,099,554 shares changed hands during trading, an increase of 555% from the average session volume of 473,495 shares. The stock had previously closed at GBX 20.50 ($0.26).

EKF Diagnostics Trading Down 3.6 %

The company has a market cap of £94.23 million, a PE ratio of 19.73 and a beta of 0.57. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The firm has a fifty day moving average of GBX 23.23 and a two-hundred day moving average of GBX 25.85.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, sell-side analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

Insider Activity at EKF Diagnostics

In related news, insider Gavin T. Jones bought 50,000 shares of EKF Diagnostics stock in a transaction on Tuesday, March 25th. The stock was acquired at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48). 5.24% of the stock is currently owned by corporate insiders.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.